Supplemental Reading for Chapter 1 Basic Principles of Clinical ...

1986.
103. Todd PA, Faulds D: Felodipine: A review of the
pharmacology and therapeutic use of the extended-release
formulation in cardiovascular disorders.
Drugs 44:251, 1992.
104. Hamilton BP: Treatment of essential hypertension
with PN 200-110 (isradipine). Am J Cardiol 59:141,
1987.
105. Basile JN: Treatment of the elderly hypertensive:
systolic hypertension. In Izzo JL Jr., Sica DA, Black
HR (eds): Hypertension Primer 4th ed. Dallas,
American Heart Assn, 2008, 485.
105a. Fleg JL, Aronow WS, Frishman WH: Cardiovascular
drug therapy in the elderly: benefits and challenges.
Nat Rev Cardiol 2010 in press.
106. Staessen JA, Fagard R, Thijs L, et al: Randomized
double-blind comparison of placebo and active
treatment for older patients with isolated systolic
hypertension. Lancet 350:757, 1997.
107. Forette F, Seux M-L, Staeseen JA, et al: Prevention
of dementia in randomized double-blind, placebocontrolled
systolic hypertension in Europe (SYST-
EUR). Lancet 352:1347, 1998.
108. The Seventh Report of the Joint National Committee
on Detection, Evaluation and Treatment of
High Blood Pressure (JNC-VII). JAMA 289: 2560,
2003.
109. Wang JG, Staessen JA, Gong L, et al: Chinese trial
on Isolated Systolic Hypertension in the Elderly.
Systolic Hypertension in China (SYST-CHINA)
Collaborative Group. Arch Intern Med 160:211,
2000.
110. Black HR, Elliott WJ, Weber MA, et al for the Stage
I Systolic Hypertension (SISH) Study Group: Oneyear
study of felodipine or placebo for stage 1 isolated
systolic hypertension. Hypertension 38:1118,
2001.
111. Grimm RH Jr., Black H, Rowen R, et al: Amlodipine
versus chlorthalidoneversus placebo in the
treatment of stage I isolated systolic hypertension.
Am J Hypertens 15:31, 2002.
112. Dahlof B, Lindholm LH, Hansson L, et al: Morbidity
and mortality in the Swedish Trial in Old Patients
with Hypertension (STOP-Hypertension).
Lancet 338:1281, 1991.
113. Hansson L, Lindholm LH, Ekbom I, et al: Randomized
trial of old and new antihypertensive drugs
in elderly patients: Cardiovascular mortality and
morbidity in the Swedish Trial of Old Patients with
Hypertension-2 Study. Lancet 354:1751, 1999.
114. Brown MJ, Palmer CR, Castaigne A, et al: Morbidity
and mortality in patients randomized to doubleblind
treatment with long-acting calcium channel
blocker or diuretic in the International Nifedipine
References to Chapter 8 8-5
GITS Study: Intervention as a Goal in Hypertension
Treatment (INSIGHT). Lancet 356:366, 2000.
115. Hansson L, Hedner T, Lund-Johansen P, et al:
Randomized trial of effects of calcium antagonists
compared with diuretics and beta blockers on
cardiovascular morbidity and mortality in hypertension:
The Nordic Diltiazem (NORDIL) Study.
Lancet 356:359, 2000.
116. Randomized double-blind comparison of a calcium
antagonist and a diuretic in elderly hypertensives.
National Intervention Cooperative Study in
Elderly Hypertensives Study Group. Hypertension
34:1129, 1999.
117. Hansson L, Zanchetti A, Carruthers SG, et al: Effects
of intensive blood-pressure lowering and
low-dose aspirin in patients with hypertension:
Principal results from the Hypertension Optimal
Treatment (HOT) randomized trial. Lancet
351:1755, 1998.
118. ALLHAT Officers and Coordinators: Major outcomes
in high-risk hypertensive patients randomized
to angiotensin converting enzyme inhibitor
therapy or calcium channel blocker vs diuretic: The
Antihypertensive and Lipid-Lowering Treatment
to Prevent Heart Attack Trial (ALLHAT). JAMA
288: 2981, 2002.
119. Black HR, Elliott WJ, Neaton JD, et al: Rationale
and design for the Controlled Onset Verapamil
Investigation of Cardiovascular Endpoints (CON-
VINCE). Control Clin Trials 19:370, 1998.
120. Hachamovitch R, Strom JA, Sonnenblick EH, Frishman
WH: Left ventricular hypertrophy in hypertension
and the effects of antihypertensive drug
therapy. Curr Probl Cardiol 13(6):371, 1988.
121. Sica DA: Combination calcium channel blocker
therapy in the treatment of hypertension. J Clin
Hypertens 3:322, 2001.
122. Frishman WH, Ram CVS, McMahon FG, et al:
Comparison of amlodipine and benazepril monotherapy
to combination therapy in patients with
systemic hypertension: A randomized, doubleblind,
placebo-controlled, parallel group study. J
Clin Pharmacol 35:1060, 1995.
123. Messerli F, Frishman WH, Elliott W, and the Trandolapril
Study Group: Additive effects of verapamil
and trandolapril in the treatment of hypertension.
J Hypertens 11(3 Pt 1):322, 1998.
124. Plosker GL, Robinson DM: Amlodipine/valsartan.
Fixed-dose combination in hypertension. Drugs
68: 373, 2008.
125. Sanford M, Keam SJ: Olmesartan medoxomil/amlodipine.
Drugs 69: 717, 2009.
126. Frishman WH, Hainer JW, Sugg J, and M-FACT
Study Group: A factorial study of combination